|
RMAAQV | RMAAMV | RMAFCV | RMAFFV | RMBGYV | RMBKMV | RMAHIV | OTSRCH | RMAV6V | OYFRCH | OVLRCH | RMA4KV | AAYMTQ | Z0A42Z | RMA9EV | RMALYV | RMBPAV | RMAZ0V | RMBJ8V | RMASDV |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | |
|
Compagnie Financière Richemont SA / Galderma Group AG / Nestlé S.A. | Galderma Group AG / L'Oréal S.A. / Nestlé S.A. | Compagnie Financière Richemont SA / Galderma Group AG / Hermès International S.A. / LVMH Moet Hennessy Louis Vuitton | Alcon / Galderma Group AG / Sandoz Group AG | Alcon / Galderma Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Nestlé S.A. / Novartis AG / Roche AG | Estée Lauder Co. Inc. / Galderma Group AG / L'Oréal S.A. / Unilever N.V. | Bachem Hldg. AG / Galderma Group AG / Sandoz Group AG | Compagnie Financière Richemont SA / Galderma Group AG / Givaudan | DOCMORRIS AG / Galderma Group AG | Galderma Group AG / Roche AG / Straumann Hldg. AG | Galderma Group AG / Galenica AG / Tecan Group AG | Bachem Hldg. AG / Galderma Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Sandoz Group AG | Douglas Hldg. AG / Galderma Group AG / Unilever N.V. | Compagnie Financière Richemont SA / Galderma Group AG / Swatch Group I | CREDIT SUISSE UBS MERGER / Galderma Group AG / Sonova Hldg. AG | CREDIT SUISSE UBS MERGER / Ems-Chemie Hldg. AG / Galderma Group AG / Novartis AG | CREDIT SUISSE UBS MERGER / Galderma Group AG / Tecan Group AG | Galderma Group AG / Givaudan / Ypsomed Hldg. AG |
|
||||||||||||||||||||
|
14.04.2026 | 13.10.2025 | 20.10.2025 | 29.06.2026 | 02.02.2026 | 16.02.2026 | 24.02.2026 | 02.03.2026 | 20.03.2026 | 30.09.2025 | 13.03.2026 | 07.04.2026 | 20.03.2026 | 09.10.2025 | 28.09.2026 | 19.10.2026 | 27.04.2026 | 12.10.2026 | 05.05.2026 | 11.05.2026 |
95,80 | 91,60 | 91,80 | 100,00 | 98,30 | 96,60 | 85,40 | 93,49 | 97,30 | 92,20 | 97,91 | 88,20 | 96,15 | 101,47 | 99,50 | 93,50 | 96,70 | 93,80 | 94,30 | 95,60 | |
96,60 | 92,40 | 92,60 | 100,80 | 99,10 | 97,40 | 86,40 | 94,29 | 98,10 | 93,00 | 98,71 | 89,00 | 96,95 | 101,97 | 100,50 | 97,40 | 97,80 | 94,60 | 95,10 | 99,10 |